Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Isolation of Oropouche Virus from Febrile Patient, Ecuador.

Wise EL, Pullan ST, Márquez S, Paz V, Mosquera JD, Zapata S, Jackson SK, Fejer G, Trueba G, Logue CH.

Emerg Infect Dis. 2018 May;24(5):935-937. doi: 10.3201/eid2405.171569.

2.

Mycobacterium tuberculosis Infection and Innate Responses in a New Model of Lung Alveolar Macrophages.

Woo M, Wood C, Kwon D, Park KP, Fejer G, Delorme V.

Front Immunol. 2018 Mar 12;9:438. doi: 10.3389/fimmu.2018.00438. eCollection 2018.

3.

Lung macrophage scavenger receptor SR-A6 (MARCO) is an adenovirus type-specific virus entry receptor.

Stichling N, Suomalainen M, Flatt JW, Schmid M, Pacesa M, Hemmi S, Jungraithmayr W, Maler MD, Freudenberg MA, Plückthun A, May T, Köster M, Fejer G, Greber UF.

PLoS Pathog. 2018 Mar 9;14(3):e1006914. doi: 10.1371/journal.ppat.1006914. eCollection 2018 Mar.

4.

A Potent Tartrate Resistant Acid Phosphatase Inhibitor to Study the Function of TRAP in Alveolar Macrophages.

Boorsma CE, van der Veen TA, Putri KSS, de Almeida A, Draijer C, Mauad T, Fejer G, Brandsma CA, van den Berge M, Bossé Y, Sin D, Hao K, Reithmeier A, Andersson G, Olinga P, Timens W, Casini A, Melgert BN.

Sci Rep. 2017 Oct 3;7(1):12570. doi: 10.1038/s41598-017-12623-w.

5.

Erratum for Maler et al., "Key Role of the Scavenger Receptor MARCO in Mediating Adenovirus Infection and Subsequent Innate Responses of Macrophages".

Maler MD, Nielsen PJ, Stichling N, Cohen I, Ruzsics Z, Wood C, Engelhard P, Suomalainen M, Gyory I, Huber M, Müller-Quernheim J, Schamel WW, Gordon S, Jakob T, Martin SF, Jahnen-Dechent W, Greber UF, Freudenberg MA, Fejer G.

MBio. 2017 Sep 26;8(5). pii: e01445-17. doi: 10.1128/mBio.01445-17. No abstract available.

6.

Key Role of the Scavenger Receptor MARCO in Mediating Adenovirus Infection and Subsequent Innate Responses of Macrophages.

Maler MD, Nielsen PJ, Stichling N, Cohen I, Ruzsics Z, Wood C, Engelhard P, Suomalainen M, Gyory I, Huber M, Müller-Quernheim J, Schamel WWA, Gordon S, Jakob T, Martin SF, Jahnen-Dechent W, Greber UF, Freudenberg MA, Fejer G.

MBio. 2017 Aug 1;8(4). pii: e00670-17. doi: 10.1128/mBio.00670-17. Erratum in: MBio. 2017 Sep 26;8(5):.

7.

Fast, Ultrasensitive Detection of Reactive Oxygen Species Using a Carbon Nanotube Based-Electrocatalytic Intracellular Sensor.

Rawson FJ, Hicks J, Dodd N, Abate W, Garrett DJ, Yip N, Fejer G, Downard AJ, Baronian KH, Jackson SK, Mendes PM.

ACS Appl Mater Interfaces. 2015 Oct 28;7(42):23527-37. doi: 10.1021/acsami.5b06493. Epub 2015 Oct 14.

8.

Self-renewing macrophages--a new line of enquiries in mononuclear phagocytes.

Fejer G, Sharma S, Gyory I.

Immunobiology. 2015 Feb;220(2):169-74. doi: 10.1016/j.imbio.2014.11.005. Epub 2014 Nov 11. Review.

PMID:
25468723
9.

Nontransformed, GM-CSF-dependent macrophage lines are a unique model to study tissue macrophage functions.

Fejer G, Wegner MD, Györy I, Cohen I, Engelhard P, Voronov E, Manke T, Ruzsics Z, Dölken L, Prazeres da Costa O, Branzk N, Huber M, Prasse A, Schneider R, Apte RN, Galanos C, Freudenberg MA.

Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):E2191-8. doi: 10.1073/pnas.1302877110. Epub 2013 May 24.

10.

Adenovirus-triggered innate signalling pathways.

Fejer G, Freudenberg M, Greber UF, Gyory I.

Eur J Microbiol Immunol (Bp). 2011 Dec;1(4):279-88. doi: 10.1556/EuJMI.1.2011.4.3. Epub 2011 Dec 23. Review.

11.

Absence of TRIF signaling in lipopolysaccharide-stimulated murine mast cells.

Keck S, Müller I, Fejer G, Savic I, Tchaptchet S, Nielsen PJ, Galanos C, Huber M, Freudenberg MA.

J Immunol. 2011 May 1;186(9):5478-88. doi: 10.4049/jimmunol.1000458. Epub 2011 Mar 25.

12.

Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly IC.

Lauterbach H, Bathke B, Gilles S, Traidl-Hoffmann C, Luber CA, Fejer G, Freudenberg MA, Davey GM, Vremec D, Kallies A, Wu L, Shortman K, Chaplin P, Suter M, O'Keeffe M, Hochrein H.

J Exp Med. 2010 Nov 22;207(12):2703-17. doi: 10.1084/jem.20092720. Epub 2010 Oct 25.

13.

Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel.

Schmidt M, Raghavan B, Müller V, Vogl T, Fejer G, Tchaptchet S, Keck S, Kalis C, Nielsen PJ, Galanos C, Roth J, Skerra A, Martin SF, Freudenberg MA, Goebeler M.

Nat Immunol. 2010 Sep;11(9):814-9. doi: 10.1038/ni.1919. Epub 2010 Aug 15.

PMID:
20711192
14.

Conventional bone marrow-derived dendritic cells contribute to toll-like receptor-independent production of alpha/beta interferon in response to inactivated parapoxvirus ovis.

Siegemund S, Hartl A, von Buttlar H, Dautel F, Raue R, Freudenberg MA, Fejer G, Büttner M, Köhler G, Kirschning CJ, Sparwasser T, Alber G.

J Virol. 2009 Sep;83(18):9411-22. doi: 10.1128/JVI.02362-08. Epub 2009 Jul 1.

15.

Key role of splenic myeloid DCs in the IFN-alphabeta response to adenoviruses in vivo.

Fejer G, Drechsel L, Liese J, Schleicher U, Ruzsics Z, Imelli N, Greber UF, Keck S, Hildenbrand B, Krug A, Bogdan C, Freudenberg MA.

PLoS Pathog. 2008 Nov;4(11):e1000208. doi: 10.1371/journal.ppat.1000208. Epub 2008 Nov 14.

16.

Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity.

Martin SF, Dudda JC, Bachtanian E, Lembo A, Liller S, Dürr C, Heimesaat MM, Bereswill S, Fejer G, Vassileva R, Jakob T, Freudenberg N, Termeer CC, Johner C, Galanos C, Freudenberg MA.

J Exp Med. 2008 Sep 1;205(9):2151-62. doi: 10.1084/jem.20070509. Epub 2008 Aug 25.

17.

Latency type-specific distribution of epigenetic marks at the alternative promoters Cp and Qp of Epstein-Barr virus.

Fejer G, Koroknai A, Banati F, Györy I, Salamon D, Wolf H, Niller HH, Minarovits J.

J Gen Virol. 2008 Jun;89(Pt 6):1364-70. doi: 10.1099/vir.0.83594-0.

PMID:
18474551
18.

Lipopolysaccharide sensing an important factor in the innate immune response to Gram-negative bacterial infections: benefits and hazards of LPS hypersensitivity.

Freudenberg MA, Tchaptchet S, Keck S, Fejer G, Huber M, Schütze N, Beutler B, Galanos C.

Immunobiology. 2008;213(3-4):193-203. doi: 10.1016/j.imbio.2007.11.008. Epub 2007 Dec 27. Review.

PMID:
18406367
19.

Acetylated histone H3 and H4 mark the upregulated LMP2A promoter of Epstein-Barr virus in lymphoid cells.

Gerle B, Koroknai A, Fejer G, Bakos A, Banati F, Szenthe K, Wolf H, Niller HH, Minarovits J, Salamon D.

J Virol. 2007 Dec;81(23):13242-7. Epub 2007 Sep 26.

20.

Adenovirus infection dramatically augments lipopolysaccharide-induced TNF production and sensitizes to lethal shock.

Fejér G, Szalay K, Gyory I, Fejes M, Kúsz E, Nedieanu S, Páli T, Schmidt T, Siklódi B, Lázár G Jr, Lázár G Sr, Duda E.

J Immunol. 2005 Aug 1;175(3):1498-506.

21.

Requirement for TLR9 in the immunomodulatory activity of Propionibacterium acnes.

Kalis C, Gumenscheimer M, Freudenberg N, Tchaptchet S, Fejer G, Heit A, Akira S, Galanos C, Freudenberg MA.

J Immunol. 2005 Apr 1;174(7):4295-300.

22.
23.

PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing.

Gyory I, Wu J, Fejér G, Seto E, Wright KL.

Nat Immunol. 2004 Mar;5(3):299-308. Epub 2004 Feb 22.

PMID:
14985713
24.

Phosphorus-based SAHA analogues as histone deacetylase inhibitors.

Kapustin GV, Fejér G, Gronlund JL, McCafferty DG, Seto E, Etzkorn FA.

Org Lett. 2003 Aug 21;5(17):3053-6.

PMID:
12916979
26.

Targeted recruitment of a histone H4-specific methyltransferase by the transcription factor YY1.

Rezai-Zadeh N, Zhang X, Namour F, Fejer G, Wen YD, Yao YL, Gyory I, Wright K, Seto E.

Genes Dev. 2003 Apr 15;17(8):1019-29.

27.
28.

Functional domains of histone deacetylase-3.

Yang WM, Tsai SC, Wen YD, Fejer G, Seto E.

J Biol Chem. 2002 Mar 15;277(11):9447-54. Epub 2002 Jan 4.

29.
30.

Development of competitive mRNA PCR for the quantification of interleukin-6-responsive junB oncogene expression.

Igaz P, Fejér G, Szalai C, Tóth S, Falus A.

Biotechniques. 1998 May;24(5):854-60.

31.

Mouse adenovirus type 1 causes a fatal hemorrhagic encephalomyelitis in adult C57BL/6 but not BALB/c mice.

Guida JD, Fejer G, Pirofski LA, Brosnan CF, Horwitz MS.

J Virol. 1995 Dec;69(12):7674-81.

32.

Prolonged survival of pancreatic islet allografts mediated by adenovirus immunoregulatory transgenes.

Efrat S, Fejer G, Brownlee M, Horwitz MS.

Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):6947-51.

33.

Model systems for studying the effects of adenovirus E3 genes on virulence in vivo.

Horwitz MS, Tufariello J, Grunhaus A, Fejer G.

Curr Top Microbiol Immunol. 1995;199 ( Pt 3):195-211. Review. No abstract available.

PMID:
7555077
34.

Characterization of transgenic mice containing adenovirus early region 3 genomic DNA.

Fejer G, Gyory I, Tufariello J, Horwitz MS.

J Virol. 1994 Sep;68(9):5871-81.

35.

Multiple enlargements in the right inverted terminal repeat of the DNA of canine adenovirus type 2.

Fejér G, Berencsi G, Ruzsics Z, Belák S, Linné T, Nász I.

Acta Microbiol Hung. 1992;39(2):159-68.

PMID:
1307439
36.

Characterization of an intermediate adenovirus strain.

Fejér G, Kiss A, Lengyel A, Ruzsics Z, Berencsi G, Nász I.

Acta Microbiol Hung. 1990;37(3):315-8.

PMID:
2100904
37.

Molecular cloning and physical mapping of the DNA of human adenovirus type 35.

Kang WG, Berencsi G, Takács M, Ascher Z, Fejér G, Nász I.

Acta Microbiol Hung. 1989;36(1):67-75.

PMID:
2603646
38.

Relationship of E1 and E3 regions of human adenovirus 35 to those of human adenovirus subgroups A, C and D.

Kang WG, Berencsi G, Bánrévi A, Ascher Z, Fejér G, Takács M, Kiss A, Nász I.

Acta Microbiol Hung. 1989;36(4):445-57.

PMID:
2534900
39.

Monoclonal antibodies to adenovirus type 35 hexon.

Adám E, Erdei J, Lengyel A, Fejér G, Fachet J, Nász I.

Intervirology. 1987;27(1):9-16.

PMID:
3610573

Supplemental Content

Support Center